Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Pentoxifylline for Radiation-Induced Fibrosis
NCT00001437Phase 2Completed
- Sponsor
- National Cancer Institute
- Start
- Jun 1995
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 2, open-label, single-arm trial of pentoxifylline in radiation-induced fibrosis (RIF), sponsored by National Cancer Institute. Primary endpoints: Objective Response Parameters at 16 weeks and Subjective Response Parameters at 16 weeks. Started Jun 1995; status: completed.
02
Drugs
pentoxifylline
03
Conditions
radiation-induced fibrosis (RIF)
Beyond the preview
Go deeper on NCT00001437.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00001437.